Gentian Diagnostics
45,7 NOK 0 %Vær den første som følger denne virksomhed
Gentian Diagnostics is a Norwegian company that develops various products in healthcare. Examples are diagnostic tests with the goal of developing and streamlining diagnostic treatment, which includes treatment of cancer and cardiovascular disease. A large part of the business includes R&D development. The company was founded in 1998 and is headquartered in Moss.
Omsætning
111,92 mio.
EBIT %
-20,76 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
GENT
Daglig lav / høj pris
42 / 46
NOK
Markedsværdi
704,8 mio. NOK
Aktieomsætning
68,92 t NOK
Volumen
1,5 t
Finanskalender
Delårsrapport
24.08.2023
Delårsrapport
26.10.2023
Viser Alle indholdstyper